| WKN: | A2P5PP |
| ISIN: | US5171251003 |
| Land: | USA |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die Zafgen-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 24. März 2026 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2020 | 12,24 | 16,08 | 31,37% |
| 2 | 2017 | 37,12 | 46,79 | 26,05% |
| 3 | 2026 | 3,32 | 3,78 | 13,86% |
| 4 | 2023 | 3,72 | 4,08 | 9,68% |
| 5 | 2018 | 46,79 | 51,24 | 9,51% |
| 6 | 2024 | 4,08 | 3,70 | -9,31% |
| 7 | 2025 | 3,70 | 3,32 | -10,27% |
| 8 | 2021 | 16,08 | 9,35 | -41,85% |
| 9 | 2016 | 72,02 | 37,12 | -48,46% |
| 10 | 2022 | 9,35 | 3,72 | -60,21% |
| 11 | 2019 | 51,24 | 12,24 | -76,11% |
| 12 | 2015 | 311,62 | 72,02 | -76,89% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2015 | 311,62 | 72,02 | -76,89% |
| 2 | 2019 | 51,24 | 12,24 | -76,11% |
| 3 | 2022 | 9,35 | 3,72 | -60,21% |
| 4 | 2016 | 72,02 | 37,12 | -48,46% |
| 5 | 2021 | 16,08 | 9,35 | -41,85% |
| 6 | 2025 | 3,70 | 3,32 | -10,27% |
| 7 | 2024 | 4,08 | 3,70 | -9,31% |
| 8 | 2018 | 46,79 | 51,24 | 9,51% |
| 9 | 2023 | 3,72 | 4,08 | 9,68% |
| 10 | 2026 | 3,32 | 3,78 | 13,86% |
| 11 | 2017 | 37,12 | 46,79 | 26,05% |
| 12 | 2020 | 12,24 | 16,08 | 31,37% |